Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling
APMIS · 2025
DOI: 10.1111/apm.13507 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Mi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Yichang Central People's Hospital, Yichang, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Toll-Like Receptor 4, Mice, Inbred BALB C, NF-kappa B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
The Gram‐negative bacterium Klebsiella pneumoniae ( K. pneumoniae ) is one major causative agent of community‐ and hospital‐acquired pneumonia. Echinacoside (ECH) is a phenylethanoid glycoside isolated from Cistanche deserticola that possesses anti‐inflammatory activity. Our research aimed to confirm whether ECH alleviates K. pneumoniae ‐induced pneumonia and explore the underlying regulatory mechanisms. BEAS‐2B cells and BALB/c mice were infected by K. pneumoniae to establish the cellular and animal models, respectively, followed by ECH treatment. Inflammatory cytokine levels were detected by RT‐qPCR and ELISA. The lung wet/dry (W/D) weight ratio and the myeloperoxidase (MPO) activity in lung tissues were examined. The pulmonary histopathologic changes were observed through hematoxylin and eosin (H&E) staining. The levels of TLR4/NF‐κB pathway‐associated molecules were estimated through western blotting, immunohistochemical, and immunohistochemical staining. K. pneumoniae infection caused lung histopathologic damage, enhanced MPO activity, elevated lung W/D weight ratio, and upregulated inflammatory cytokine levels in mice and promoted inflammatory cytokine expression in BEAS‐2B cells, which were reversed by ECH treatment. K. pneumoniae infection‐induced upregulation in TLR4, phosphorylated (p)‐p65, and p‐IκBα levels, and downregulation in IκBα levels in BEAS‐2B cells and pneumonia mice were overturned by ECH treatment. ECH ameliorates K. pneumoniae ‐induced pneumonia through suppressing the TLR4/NF‐κB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory, Yichang Central People's Hospital, Yichang, China.
ORCID-Profile: Ming Zhan
Zitieren
APA
Zhang, M., Zhan, M., & Song, X. (2025). Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling. APMIS. https://doi.org/10.1111/apm.13507
Vancouver
Zhang M, Zhan M, Song X. Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling. APMIS. 2025. doi:10.1111/apm.13507
BibTeX
@article{Zhang2025,
author = {Zhang, Mi and Zhan, Ming and Song, Xinyu},
title = {Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.13507}
}
EUVIMED